← Open Payments lookup

LAURA HALL: Open Payments

NPI 1629520937 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,715 in 102 payments from 16 companies in 2025. Trend: 2023 $2,471 · 2024 $2,097 · 2025 $1,715

Food & beverage: $1,715
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$425
ABBVIE INC.33$346
Neurocrine BioSciences, Inc.7$137
Otsuka America Pharmaceutical, Inc.6$127
Alkermes, Inc.6$121
Takeda Pharmaceuticals U.S.A., Inc.5$103
Teva Pharmaceuticals USA, Inc.4$93
Vanda Pharmaceuticals Inc.3$83
E.R. Squibb & Sons, L.L.C.3$71
Axsome Therapeutics, Inc.3$61

Products named: CAPLYTA, VRAYLAR, INGREZZA, LYBALVI, TRINTELLIX, FANAPT, COBENFY, UZEDY.

Industry payments across OK — which companies pay providers there.